Tuesday, November 5, 2024
Subscribe American Journal of Medicine Free Newsletter
Rheumatologyfractures

fractures

What's New from AJM

Western Osteoporosis Alliance Clinical Practice Series: Evaluating the Balance of Benefits...

0
Osteoporosis is a chronic disease that requires life-long strategies to reduce fracture risk. Few trials have investigated the balance of benefits and risk with long-term use of osteoporosis therapies, and fewer still have investigated the consequences of treatment discontinuation. The best available evidence suggests that up to 10 years of treatment with an oral bisphosphonate maintains the degree of...